KORU Medical Systems Announces Collaboration With Global Pharma Company For Feasibility Study Using Freedom Infusion System For Subcutaneous Oncology Biologic Drug
Portfolio Pulse from Benzinga Newsdesk
KORU Medical Systems has announced a collaboration with a global pharmaceutical company to conduct a feasibility study using its Freedom Infusion System for a subcutaneous oncology biologic drug.
June 04, 2024 | 8:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
KORU Medical Systems has entered into a collaboration with a global pharmaceutical company to explore the use of its Freedom Infusion System for a subcutaneous oncology biologic drug. This partnership could potentially expand KRMD's market reach and product applications.
The collaboration with a global pharmaceutical company indicates a significant opportunity for KORU Medical Systems to expand the application of its Freedom Infusion System into the oncology market. This could lead to increased demand and revenue if the feasibility study is successful.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100